Last updated: February 20, 2026
What is the scope of patent DK1455756?
Patent DK1455756 pertains to a pharmaceutical invention. Its scope focuses on a specific formulation or method involving a drug compound, possibly emphasizing novel uses, delivery mechanisms, or compositions. The patent covers claims designed to prevent others from manufacturing, using, or selling the invention within territories where the patent is enforced.
The patent was filed in Denmark, indicating territorial rights limited primarily to Denmark. Given the European patent framework, similar protections might be sought through European patents or PCT applications, but these would be distinct filings from DK1455756.
Key Points:
- Protects a specific drug compound or formulation.
- Likely covers methods of use or manufacturing.
- Territorial rights confined to Denmark unless extended via European or international patents.
What are the primary claims of DK1455756?
Claims define the legal boundaries of the patent. Although exact claim language is unavailable here, typical pharmaceutical patents include:
- Compound Claims: Covering the chemical structure or pharmaceutically active ingredients.
- Method Claims: Describing specific methods of synthesis, formulation, or administration.
- Use Claims: Protecting novel therapeutic uses of known compounds.
- Formulation Claims: Covering specific dosages, carriers, or delivery systems.
In Denmark, patent claims typically range from broad (covering general classes of compounds) to narrow (specific formulations or doses). The patent likely includes multiple claims, trying to balance breadth with enforceability.
Typical claim categories:
- Active ingredient composition.
- Specific salts or derivatives.
- Administration method.
- Combination with other therapeutic agents.
How does DK1455756 fit into the global patent landscape?
Patent Family and Priority Status
Most pharmaceutical patents are part of a patent family, seeking protection across multiple jurisdictions via the Patent Cooperation Treaty (PCT) or direct filings. DK1455756 is likely a national patent, but similar or related patents could exist in Europe, the US, and Asia.
Similar Patents and Infringement Risks
- Identify overlapping patents with similar compounds or uses.
- Examine patent databases (e.g., Lens, Espacenet) for related filings.
- Overlaps in claims could lead to infringement disputes or licensing opportunities.
Patentability and Novelty
- The patent must meet novelty, inventive step, and industrial applicability requirements within Denmark.
- Prior art includes prior publications, existing drugs, or previously filed patents involving similar compounds.
Competitive Landscape
- Major competitors may hold patents on similar formulations or active compounds.
- Patent expiries in key markets can influence generic entry margins.
- Licensing or patent challenges can modify the landscape.
Patent Extensions and Lifespan
- The patent's expiry date, typically 20 years from filing, can be extended via supplementary protection certificates (SPCs) in Europe, prolonging exclusivity.
- The status and term of DK1455756 depend on its earliest priority date.
What are the implications for R&D and commercial strategy?
- Validation of protection scope influences licensing negotiations or litigation.
- Broader claims can block competitors but are harder to defend.
- Narrow claims may limit enforcement or market potential.
Summary: Key points
| Aspect |
Details |
| Scope |
Protects a specific drug formulation/method, limited geographically to Denmark unless extended. |
| Claims |
Cover chemical compounds, methods, uses, and formulations; exact language will determine enforceability. |
| Landscape |
Related patents likely in Europe and globally; overlaps can pose infringement or licensing opportunities. |
| Patent term |
Usually 20 years from filing; extensions possible via SPCs. |
Key Takeaways
- DK1455756 likely covers a specific pharmaceutical compound or formulation with defined claims.
- Its enforceability depends on claim specificity and prior art.
- The patent landscape surrounding this patent influences market exclusivity, competitive positioning, and potential for licensing.
- Strategic considerations include scope, claim strength, and patent family breadth.
FAQs
Q1. How broad are the claims typically in Danish pharmaceutical patents?
Claims can range from broad (covering entire classes of compounds) to narrow (specific formulations). Their breadth depends on prosecution history and prior art.
Q2. Can DK1455756 be enforced outside Denmark?
No. It provides protection solely within Denmark unless extensions through regional or international patents are secured.
Q3. What is the likelihood of patent challenges against DK1455756?
Challengers may cite prior art to argue invalidity, especially if the patent's claims are broad or lack novelty. European Patent Office (EPO) opposition procedures could also be utilized if related patents are registered there.
Q4. How can competitors bypass this patent?
By developing different compounds, alternative formulations, or using unique methods not covered by the claims; patent invalidation based on prior art is also possible.
Q5. What is the significance of the patent’s filing date?
The filing date establishes priority and influences patent term calculation. It also affects the novelty assessment against prior art.
References
-
European Patent Office. (2022). Patent landscape analysis. Retrieved from https://www.epo.org/patent-issues/technology.html
-
Danish Patent and Trademark Office. (2023). Patent law overview. Retrieved from https://dpma.dk/en
-
WIPO. (2023). Patent cooperation treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
